Landscape of EBV-positive gastric cancer Motonobu SaitoKoji Kono Review Article 22 July 2021 Pages: 983 - 989
Nationwide evaluation of mutation-tailored treatment of gastrointestinal stromal tumors in daily clinical practice Elisabeth M. P. SteeghsHans GelderblomMarjolijn J. L. Ligtenberg Original Article Open access 28 April 2021 Pages: 990 - 1002
WEE1 inhibition reverses trastuzumab resistance in HER2-positive cancers Mei-Hua JinAh-Rong NamDo-Youn Oh Original Article 16 March 2021 Pages: 1003 - 1020
EPRS/GluRS promotes gastric cancer development via WNT/GSK-3β/β-catenin signaling pathway Hui LiuMangaladoss FredimosesZigang Dong Original Article 19 March 2021 Pages: 1021 - 1036
Propranolol suppresses gastric cancer cell growth by regulating proliferation and apoptosis Masahiro KohTsuyoshi TakahashiYuichiro Doki Original Article 29 March 2021 Pages: 1037 - 1049
Crosstalk between WNT and STAT3 is mediated by galectin-3 in tumor progression Seok-Jun KimHyeok-Gu KangKyung-Hee Chun Original Article 08 April 2021 Pages: 1050 - 1062
LRRC8A influences the growth of gastric cancer cells via the p53 signaling pathway Kento KurashimaAtsushi ShiozakiEigo Otsuji Original Article 16 April 2021 Pages: 1063 - 1075
EBNA1 inhibitors have potent and selective antitumor activity in xenograft models of Epstein–Barr virus-associated gastric cancer Samantha S. SoldanEmma M. AndersonTroy E. Messick Original Article 30 April 2021 Pages: 1076 - 1088
Expression of CD44 variant 9 induces chemoresistance of gastric cancer by controlling intracellular reactive oxygen spices accumulation Tomoko JogoEiji OkiMasaki Mori Original Article 08 May 2021 Pages: 1089 - 1099
Correction to: Expression of CD44 variant 9 induces chemoresistance of gastric cancer by controlling intracellular reactive oxygen spices accumulation Tomoko JogoEiji OkiMasaki Mori Correction 05 July 2021 Pages: 1100 - 1101
Indolent feature of Helicobacter pylori-uninfected intramucosal signet ring cell carcinomas with CDH1 mutations Mitsuhiro NikaidoNobuyuki KakiuchiHiroshi Seno Original Article 07 May 2021 Pages: 1102 - 1114
Optimized PD-L1 scoring of gastric cancer Birgid Schoemig-MarkiefkaJana EschbachAlexander Quaas Original Article Open access 05 May 2021 Pages: 1115 - 1122
Incidence and treatment outcomes of metachronous gastric cancer occurring after curative endoscopic submucosal dissection of undifferentiated-type early gastric cancer: Japan Clinical Oncology Group study—post hoc analysis of JCOG1009/1010 Seiichiro AbeKohei TakizawaManabu Muto Original Article 31 March 2021 Pages: 1123 - 1130
QOL assessment after palliative surgery for malignant bowel obstruction caused by peritoneal dissemination of gastric cancer: a prospective multicenter observational study Yuichi ItoKazumasa FujitaniMasato Kondo Original Article 31 March 2021 Pages: 1131 - 1139
Short- and long-term oncological outcomes of totally laparoscopic gastrectomy versus laparoscopy-assisted gastrectomy for clinical stage I gastric cancer Yusuke MuneokaManabu OhashiSouya Nunobe Original Article 15 March 2021 Pages: 1140 - 1149
Oral nutritional supplements versus a regular diet alone for body weight loss after gastrectomy: a phase 3, multicenter, open-label randomized controlled trial Yasuhiro MiyazakiTakeshi OmoriOsaka University Clinical Research Group for Gastroenterological Study Original Article 09 April 2021 Pages: 1150 - 1159
Recurrence of gastric cancer caused by implantation of tumor cells after curative endoscopic submucosal dissection Michiko NakaokaTetsuo NemotoTohru Goto Case Report 15 April 2021 Pages: 1160 - 1166
Letter to editor: development and internal validation of a diagnostic score for gastric linitis plastic Qiang WangChaoran Yu Letter to the Editor 16 April 2021 Pages: 1167 - 1168